Skip to content

Resting Energy Expenditure and Substrate Consumption in Cardiac Arrest Patients Under Target Temperature Management

Resting Energy Expenditure and Substrate Consumption in Cardiac Arrest Patients Under Target Temperature Management

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06575101
Enrollment
40
Registered
2024-08-28
Start date
2024-06-01
Completion date
2028-12-31
Last updated
2026-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Nutrition, Resting Energy Expenditure, Targeted Temperature Management

Brief summary

This study is a single-center, prospective, observational study. According to the sample size formula, an estimated 40 cases should be collected, all of whom are from the emergency intensive care unit. After successful cardiopulmonary resuscitation, the enrolled patients will be transferred to the emergency intensive care unit for further standardized target temperature management (TTM). They will be divided into 33 ° C hypothermia group and 36 ° C hypothermia group according to the patient's core body temperature. The baseline data of the patients will be collected at the beginning. After admission to the hospital, they were fasted within 24 hours to reach the target temperature, and then 20kcal/kg/d parenteral nutrition will be given. At selected time points (T0: the initial time point before TTM; T1: the core temperature was reduced to 33 ° C or 36 ° C; T2-T4: 33 ° C or 36 ° C was maintained for 24h, 48h, 72h; T5: the end of rewarming; Tend: the last REE measurement before discharge or death) , various observation indicators will be collected, including resting energy expenditure (REE), glucose oxidation rate, fat oxidation rate, protein oxidation rate, and metabolism of three major nutrients Proportion. Neurological outcomes were followed up 28 days after onset according to the Cerebral Performance Categories (CPC) score.

Interventions

Target Temperature Management Treatment

Sponsors

Tang Ziren
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be admitted to the emergency department of Beijing Chao-yang Hospital, Capital Medical University; * Successfully resuscitated, and are unconscious after restoration of spontaneous circulation (ROSC); * Be admitted to the intensive care unit (ICU) for advanced life support such as endotracheal intubation after restoration of spontaneous circulation (ROSC); * Accepted target temperature management (TTM) therapy after restoration of spontaneous circulation (ROSC);

Exclusion criteria

* Age \> 18 years old; * Incomplete clinical data and loss of follow-up; * Traumatic brain injury or cerebrovascular accident revealed by computed tomography (CT); * Severe metabolic abnormalities are known: cachexia, thyroid dysfunction, and cancer; * Indirect calorimetry measurement is not possible such as sustained oxygen concentration \> 70%; * There were no signs of resuscitation at the time of admission;

Design outcomes

Primary

MeasureTime frameDescription
Resting Energy Expenditure7 daysThe primary outcome measure is the changes resting energy expenditure(REE) in the patients at various time points. patients at various time points.
Glucose oxidation rate7 daysThe primary outcome measure is the statistical differences in Glucose oxidation rate between the two groups of patients at various time points.
Fat oxidation rate7 daysThe primary outcome measure is the statistical differences in fat oxidation rate between the two groups of patients at various time points.
Protein oxidation rate7 daysThe primary outcome measure is the statistical differences in protein oxidation rate between the two groups of patients at various time points.
Metabolic supply proportion of glucose, fat, protein7 daysThe primary outcome measure is the statistical differences in metabolic supply proportion of glucose, fat, protein (measuring by indirect calorimetry) between the two groups of patients at various time points.

Secondary

MeasureTime frameDescription
CPC score28 daysCPC = Cerebral Performance Category Score.There are 5 levels of CPC score. CPC 1-2 means good prognosis of neurological function, CPC3-5 means bad prognosis of neurological function. The Secondary Outcome of the study is the statistical differences in the proportion of patients with good neurological outcome(CPC1-2) in the two groups at 28 days after CA.
Mortality rate28 daysThe Secondary Outcome of the study is the statistical differences in the mortality rate of two groups at 28 days after CA.

Countries

China

Contacts

CONTACTZiren Tang, MD
tangziren1970@163.com010-85231530

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 13, 2026